CCEW Charity Commission profile

THE TOM TOWLER EBV-HLH CHARITY

Registered charity 1218180 · organisation 5284255

01 Identity

Registration and reporting

Registration status
Registered
Reporting status
New
Charity type
CIO
Registered
21 May 2026
Removed
Not supplied
Financial period
Not supplied – Not supplied
Latest income
Not supplied
Latest expenditure
Not supplied
In administration
No
Insolvent
No
CIO
Yes

03 Official extract

Charity Area Of Operation

Geographic Area Type
Region
Geographic Area Description
Throughout England And Wales
Welsh Ind
No
Geographic Area Type
Country
Geographic Area Description
Scotland
Parent Geographic Area Type
Continent
Parent Geographic Area Description
Europe
Welsh Ind
No
Geographic Area Type
Country
Geographic Area Description
Northern Ireland
Parent Geographic Area Type
Continent
Parent Geographic Area Description
Europe
Welsh Ind
No

04 Official extract

Charity Classification

Classification Code
103
Classification Type
What
Classification Description
The Advancement Of Health Or Saving Of Lives
Classification Code
307
Classification Type
How
Classification Description
Provides Advocacy/advice/information
Classification Code
207
Classification Type
Who
Classification Description
The General Public/mankind
Classification Code
308
Classification Type
How
Classification Description
Sponsors Or Undertakes Research

05 Official extract

Charity Event History

Charity Name
THE TOM TOWLER EBV-HLH CHARITY
Charity Event Order
1
Event Type
CIO registration
Date Of Event
2026-05-21T00:00:00

06 Official extract

Charity Governing Document

Governing Document Description
CIO - FOUNDATION Registered 21 May 2026
Charitable Objects
THE OBJECTS OF THE CIO ARE, FOR THE PUBLIC BENEFIT, THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH AMONG PATIENTS AFFECTED BY THE EPSTEIN?BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ("EBV-HLH"), THEIR FAMILIES AND CARERS, IN PARTICULAR BUT NOT EXCLUSIVELY BY:A. THE PROMOTION AND FURTHERANCE OF SCIENTIFIC RESEARCH INTO THE PHYSIOLOGY AND PATHOLOGY OF EBV-HLH AND THE AETIOLOGY OF EBV-HLH DISEASE, THE USEFUL RESULTS OF WHICH WILL BE DISSEMINATED FOR THE BENEFIT OF THE PUBLIC; B. THE DEVELOPMENT OF MORE ACCURATE MEANS OF DIAGNOSIS, IMPROVED PROTOCOLS FOR MANAGEMENT OF PATIENTS AND ULTIMATELY MEASURES FOR PREVENTION OF EBV-HLH DISEASE; C. THE PROVISION AND DISSEMINATION OF INFORMATION, EDUCATION AND KNOWLEDGE IN SUPPORT OF PATIENTS AND FAMILIES AFFECTED BY EBV-HLH DISEASE TO INCLUDE ALL OR ANY MEDICAL PROFESSIONALS AND THE GENERAL PUBLIC; ANDD. COLLABORATION WITH INTERESTED INDIVIDUALS AND ORGANISATIONS.